Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 28-Nov 2018. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 109667401000001118 | Nalidixic acid 300mg/5ml oral suspension sugar free (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| 109667501000001119 | Nalidixic acid 300mg/5ml oral suspension sugar free | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Nalidixic acid 300mg/5ml oral suspension sugar free 120 ml | Has VMP | False | Nalidixic acid 300mg/5ml oral suspension sugar free | Inferred relationship | Existential restriction modifier | |
| Negram 300mg/5ml oral suspension (Sanofi-Synthelabo Ltd) | Is a | False | Nalidixic acid 300mg/5ml oral suspension sugar free | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR